Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Herzig

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Lancet (London, England)|December 7, 1985
Bone-marrow transplantation for chronic myelogenous leukaemiaJ M Goldman, M M Bortin, R E Champlin, et al.
Blood|June 1, 1985
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: a pilot studyS N Wolff, J Marion, R S Stein, et al.
Blood|March 1, 1995
High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant GroupR A Brown, S N Wolff, J W Fay, et al.
Lancet (London, England)|April 4, 1987
Bone-marrow transplantation in high-risk acute lymphoblastic leukaemia in first and second remissionR H Herzig, M M Bortin, A J Barrett, et al.
Blood|July 1, 1984
Incidence of acute graft-versus-host disease with and without methotrexate prophylaxis in allogeneic bone marrow transplant patientsH M Lazarus, P F Coccia, R H Herzig, et al.
Leukemia & Lymphoma|July 1, 1996
High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant GroupR A Brown, S N Wolff, J W Fay, et al.
Bone Marrow Transplantation|April 1, 1992
Second HLA-identical sibling transplants for leukemia recurrenceM Mrsíc, M M Horowitz, K Atkinson, et al.
Blood|May 15, 1992
Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers?M M Horowitz, D Przepiorka, R E Champlin, et al.
Seminars in Oncology|February 1, 1990
High-dose N,N',N"-triethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase I studiesS N Wolff, R H Herzig, J W Fay, et al.
Cleveland Clinic Journal of Medicine|May 1, 1989
Computer-assisted audits of blood component transfusionG A Hoeltge, J C Brown, R H Herzig, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|December 7, 1985
Bone-marrow transplantation for chronic myelogenous leukaemiaJ M Goldman, M M Bortin, R E Champlin, et al.
Blood|June 1, 1985
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: a pilot studyS N Wolff, J Marion, R S Stein, et al.
Blood|March 1, 1995
High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant GroupR A Brown, S N Wolff, J W Fay, et al.
Lancet (London, England)|April 4, 1987
Bone-marrow transplantation in high-risk acute lymphoblastic leukaemia in first and second remissionR H Herzig, M M Bortin, A J Barrett, et al.
Blood|July 1, 1984
Incidence of acute graft-versus-host disease with and without methotrexate prophylaxis in allogeneic bone marrow transplant patientsH M Lazarus, P F Coccia, R H Herzig, et al.
Leukemia & Lymphoma|July 1, 1996
High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant GroupR A Brown, S N Wolff, J W Fay, et al.
Bone Marrow Transplantation|April 1, 1992
Second HLA-identical sibling transplants for leukemia recurrenceM Mrsíc, M M Horowitz, K Atkinson, et al.
Blood|May 15, 1992
Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers?M M Horowitz, D Przepiorka, R E Champlin, et al.
Seminars in Oncology|February 1, 1990
High-dose N,N',N"-triethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase I studiesS N Wolff, R H Herzig, J W Fay, et al.
Cleveland Clinic Journal of Medicine|May 1, 1989
Computer-assisted audits of blood component transfusionG A Hoeltge, J C Brown, R H Herzig, et al.
Pageof 10